Intel's revenue soars 25%, but stock price tumbles

Intel's stock faced renewed pressure, dropping approximately 2.6% in Wall Street trading on Monday, following a 7.9% slide the previous Friday. This downturn occurred despite the company announcing its strongest quarterly revenue growth in over 15 years.

The tech giant reported second-quarter revenues of $16.1 billion, a significant 25% increase compared to the same period last year. This surge was largely fueled by a 59% year-over-year jump in revenue from its data center and artificial intelligence products, which reached $6.3 billion. This highlights the substantial demand in the booming AI market.

However, investors appear cautious. Following the release of its earnings report, Intel's shares fell sharply. Analysts, including those cited by Yahoo Finance and Bloomberg, point to concerns about profit margins and intense market competition. Investors are increasingly looking beyond just AI-related investments to see tangible results and a sustainable recovery strategy from Intel.

Looking ahead, Intel projects third-quarter 2026 revenues to be between $15.8 billion and $16.8 billion. The company is also benefiting from the rise of "agentive AI," where autonomous agents perform tasks like coding. CEO Lip-Bu Tan aims to reclaim technological leadership and challenge rivals like Nvidia and AMD in the lucrative AI chip market.

Shay Boloor, chief market strategist at Futurum Group, noted that Intel's stock could continue to rise if the company successfully translates current data center demand into sustained revenue growth, improves its foundry business profitability, and secures external clients to validate its manufacturing recovery. Investors will be closely watching if Intel's accelerated revenue growth can keep pace with its expected increase in spending.

“

The action may continue to revalue if Intel manages to convert the current data center shortage into sustained revenue growth, improves the profitability of its foundry business, and finally announces the external customers necessary to validate the next phase of manufacturing recovery.